Kriya Announces Publication of Preclinical Data Showing AAV-FGF21 Gene Therapy Extended Health Span and Lifespan in Aged Mice
AI Briefing
- • Kriya announces publication of preclinical data on AAV-FGF21 gene therapy for extended health span and lifespan.
- • The therapy showed significant benefits in aged mice, extending their health span and lifespan.
- • The study results are based on preclinical data in mice, with no human clinical trials mentioned.
Context
Kriya has announced the publication of preclinical data. The data shows that AAV-FGF21 gene therapy extended health span and lifespan in aged mice.
The publication of this data matters as it demonstrates the potential of AAV-FGF21 gene therapy to extend health span and lifespan.
Advertisement